Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
4.510
+0.170 (3.92%)
May 20, 2026, 9:43 AM EDT - Market open
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $253.48 million as of May 20, 2026. Its market cap has increased by 93.82% in one year.
Market Cap
253.48M
Enterprise Value
69.56M
1-Year Change
93.82%
Ranking
Category
Stock Price
$4.51
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $253.48M, an increase of 46.39%. That is a compound annual growth rate of 6.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 243.93M | -14.60% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eledon Pharmaceuticals | 276.74M |
| MacroGenics | 276.49M |
| Nuvectis Pharma | 275.87M |
| AC Immune | 274.79M |
| Inhibikase Therapeutics | 274.38M |
| Compugen | 270.42M |
| ALX Oncology Holdings | 269.12M |
| Anavex Life Sciences | 266.89M |